Published in Respir Med on September 01, 2002
Azithromycin for prevention of exacerbations of COPD. N Engl J Med (2011) 8.66
Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study. Am J Respir Crit Care Med (2011) 2.64
Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study. Eur Respir J (2012) 1.98
Present and future costs of COPD in Iceland and Norway: results from the BOLD study. Eur Respir J (2009) 1.89
Pharmacoeconomic evaluation of tiotropium bromide in the long-term treatment of chronic obstructive pulmonary disease (COPD) in Italy. Eur J Health Econ (2010) 1.41
Direct costs of chronic obstructive pulmonary disease among managed care patients. Int J Chron Obstruct Pulmon Dis (2010) 1.40
Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data. BMC Health Serv Res (2011) 1.36
Association between lung function and exacerbation frequency in patients with COPD. Int J Chron Obstruct Pulmon Dis (2010) 1.35
Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respir Res (2006) 1.33
Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review. BMC Med (2011) 1.25
Role of macrolide therapy in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2008) 1.24
Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Respir Res (2010) 1.14
COPD management costs according to the frequency of COPD exacerbations in UK primary care. Int J Chron Obstruct Pulmon Dis (2014) 1.11
Incidence and cost of pneumonia in older adults with COPD in the United States. PLoS One (2013) 0.99
Non-invasive ventilation for acute exacerbation of COPD with very high PaCO(2): A randomized controlled trial. Lung India (2010) 0.98
Health-related quality of life, utility, and productivity outcomes instruments: ease of completion by subjects with COPD. Health Qual Life Outcomes (2003) 0.94
Clinical factors affecting the direct cost of patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. Int J Med Sci (2012) 0.93
Predictors of mortality of patients with acute respiratory failure secondary to chronic obstructive pulmonary disease admitted to an intensive care unit: a one year study. BMC Pulm Med (2004) 0.92
Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004. Thorax (2005) 0.91
Clinical predictors of frequent exacerbations in subjects with severe chronic obstructive pulmonary disease (COPD). Respir Med (2010) 0.89
Airway disease: similarities and differences between asthma, COPD and bronchiectasis. Clinics (Sao Paulo) (2012) 0.88
The costs of hospitalization in patients with acute exacerbation of chronic obstructive pulmonary disease. Clinicoecon Outcomes Res (2011) 0.86
Lower 30-day readmission rates with roflumilast treatment among patients hospitalized for chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.84
Comparison of clinico-physiologic and CT imaging risk factors for COPD exacerbation. J Korean Med Sci (2011) 0.84
Pharmacoeconomics in COPD: lessons for the future. Int J Chron Obstruct Pulmon Dis (2008) 0.82
Expert Nordic perspectives on the potential of novel inhalers to overcome unmet needs in the management of obstructive lung disease. Eur Clin Respir J (2015) 0.81
COPD exacerbation frequency and its association with health care resource utilization and costs. Int J Chron Obstruct Pulmon Dis (2015) 0.81
Noninvasive ventilation in patients with chronic obstructive airway disease. Int J Chron Obstruct Pulmon Dis (2008) 0.81
Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden. Cost Eff Resour Alloc (2015) 0.80
A year in the life of German patients with COPD: the DACCORD observational study. Int J Chron Obstruct Pulmon Dis (2016) 0.79
Adjusting for COPD severity in database research: developing and validating an algorithm. Int J Chron Obstruct Pulmon Dis (2011) 0.78
Cost-effectiveness analysis of three different combinations of inhalers for severe and very severe chronic obstructive pulmonary disease patients at a tertiary care teaching hospital of South India. Perspect Clin Res (2015) 0.78
Economic Impact of Leading Prosperity Diseases: COPD in South East Europe. Front Public Health (2015) 0.78
The impact of body mass index on inpatient- versus outpatient-treated chronic obstructive pulmonary disease exacerbations. Can Respir J (2013) 0.77
Pharmaceutical Expenditure and Burden of Non-communicable Diseases in Serbia. Front Pharmacol (2016) 0.77
Newer fluoroquinolones in the treatment of acute exacerbations of COPD. Int J Chron Obstruct Pulmon Dis (2006) 0.77
Association of serum interleukin-27 with the exacerbation of chronic obstructive pulmonary disease. Physiol Rep (2014) 0.76
Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Can optimal use of spirometry have a positive impact on the progression of chronic obstructive pulmonary disease? Lung India (2012) 0.75
The evaluation of a remote support program on quality of life and evolution of disease in COPD patients with frequent exacerbations. BMC Pulm Med (2016) 0.75
Cost Analysis of Hospitalized Patients with Chronic Obstructive Pulmonary Disease: A State-Level Cross-Sectional Study. Tanaffos (2016) 0.75
Utility estimation of hypothetical chronic obstructive pulmonary disease health states by the general population and health professionals. Health Qual Life Outcomes (2015) 0.75
Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK. Clinicoecon Outcomes Res (2016) 0.75
Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population. Int J Chron Obstruct Pulmon Dis (2015) 0.75
The Burden of Illness Related to Chronic Obstructive Pulmonary Disease Exacerbations in Québec, Canada. Can Respir J (2017) 0.75
Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med (2003) 3.05
Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. Allergy (2011) 2.13
Passive smoking and respiratory symptoms in the FinEsS Study. Eur Respir J (2003) 1.86
Recommendations for epidemiological studies on COPD. Eur Respir J (2011) 1.84
Circuits and mechanisms governing hypothalamic responses to stress: a tale of two paradigms. Prog Brain Res (2000) 1.78
Effects on symptoms and lung function in humans experimentally exposed to diesel exhaust. Occup Environ Med (1996) 1.64
Relevance of allergens from cats and dogs to asthma in the northernmost province of Sweden: schools as a major site of exposure. J Allergy Clin Immunol (1999) 1.61
Importance of creatinine analyses of urine when screening for abused drugs. Clin Chem (1991) 1.60
Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler. Eur Respir J (2000) 1.58
Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis. Acta Paediatr Scand (1984) 1.54
Induction of acropetal (14)C-photosynthate transport and radial growth by indole-3-acetic acid in Pinus sylvestris shoots. Tree Physiol (1990) 1.50
Measurements of T1 and T2 over time in formalin-fixed human whole-brain specimens. Acta Radiol (1992) 1.49
A comparison of two immediate-early genes, c-fos and NGFI-B, as markers for functional activation in stress-related neuroendocrine circuitry. J Neurosci (1993) 1.45
Impact of occupation on respiratory disease. Scand J Work Environ Health (2000) 1.45
Crucial influence of solvent and chirality-the formation of helices and three-dimensional nets by hydrogen-bonded biimidazolate complexes. Chemistry (2001) 1.39
Dependence on sedative-hypnotics: neuropsychological impairment, field dependence and clinical course in a 5-year follow-up study. Br J Addict (1989) 1.38
Micro anion exchange chromatography of carbohydrate-deficient transferrin in serum in relation to alcohol consumption (Swedish Patent 8400587-5). Alcohol Clin Exp Res (1986) 1.37
The relationship between crown size and ring width in Pinus sylvestris L. stems: dependence on indole-3-acetic acid, carbohydrates and nitrogen in the cambial region. Tree Physiol (1993) 1.35
High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group. Eur Respir J (1995) 1.35
Obesity increases the risk of incident asthma among adults. Eur Respir J (2005) 1.33
Does non-responder bias have a significant effect on the results in a postal questionnaire study? Eur J Epidemiol (2001) 1.31
Obesity and nocturnal gastro-oesophageal reflux are related to onset of asthma and respiratory symptoms. Eur Respir J (2004) 1.30
Non-responders to a postal questionnaire on respiratory symptoms and diseases. Eur J Epidemiol (1999) 1.30
Salmonella typhimurium mutants that downregulate phagocyte nitric oxide production. Cell Microbiol (2000) 1.28
Relationships between human-animal interactions and productivity of commercial dairy cows. J Anim Sci (2000) 1.27
Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J Neurosci (1998) 1.27
The paraventricular nucleus of the hypothalamus and the functional neuroanatomy of visceromotor responses to stress. Prog Brain Res (1996) 1.27
Environmental tobacco smoke exposure during childhood is associated with increased prevalence of asthma in adults. Chest (2001) 1.26
A randomized study of secondary prevention of early stage problem drinkers in primary health care. Br J Addict (1989) 1.25
Different pattern of risk factors for atopic and nonatopic asthma among children--report from the Obstructive Lung Disease in Northern Sweden Study. Allergy (1999) 1.25
Structure and expression of the rat neuropeptide Y gene. Proc Natl Acad Sci U S A (1987) 1.22
Indole 3-acetic acid concentration in the leading shoot and living stem bark of Scots pine: seasonal variation and effects of pruning. Tree Physiol (1987) 1.18
A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence. Alcohol Clin Exp Res (2003) 1.17
Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents in categorically different stress paradigms. Proc Natl Acad Sci U S A (1996) 1.17
Double-contrast MR imaging of reperfused porcine myocardial infarction. An experimental study using Gd-DTAA and Dy-DTPA-BMA. Acta Radiol (1996) 1.16
Antibodies to staphylococcal teichoic acid and alpha toxin in patients with cystic fibrosis. Acta Paediatr Scand (1986) 1.15
Clinical significance of abnormal heterogeneity of transferrin in relation to alcohol consumption. Acta Med Scand (1979) 1.12
Myocardial cell death in reperfused and nonreperfused myocardial infarctions. MR imaging with dysprosioum-DTPA-BMA in the pig. Acta Radiol (1996) 1.10
Bronchoalveolar inflammation after exposure to diesel exhaust: comparison between unfiltered and particle trap filtered exhaust. Occup Environ Med (1999) 1.09
Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden. Respir Med (1998) 1.09
The Salmonella YopJ-homologue AvrA does not possess YopJ-like activity. Microb Pathog (2000) 1.08
Symptoms related to obstructive sleep apnoea are common in subjects with asthma, chronic bronchitis and rhinitis in a general population. Respir Med (2001) 1.08
Asthma, type-1 allergy and related conditions in 7- and 8-year-old children in northern Sweden: prevalence rates and risk factor pattern. Respir Med (1998) 1.08
Symptoms related to asthma and chronic bronchitis in three areas of Sweden. Eur Respir J (1994) 1.07
MR imaging in cerebral gliomas. Tissue component analysis in correlation with histopathology of whole-brain specimens. Acta Radiol (1994) 1.07
The effects of cognitive behavioral intervention on the attitude and behavior of stockpersons and the behavior and productivity of commercial dairy cows. J Anim Sci (2002) 1.06
Increasing prevalence of asthma but not of chronic bronchitis in Finland? Report from the FinEsS-Helsinki Study. Respir Med (1999) 1.06
Underdiagnosis of chronic obstructive pulmonary disease in Northern Sweden. Int J Tuberc Lung Dis (2002) 1.05
Evidence of a reduced sialic acid content in serum transferrin in male alcoholics. Alcohol Clin Exp Res (1981) 1.05
Growing up on a farm leads to lifelong protection against allergic rhinitis. Allergy (2010) 1.04
Air pollution levels, meteorological conditions and asthma symptoms. Eur Respir J (1993) 1.04
Vehicle exhaust exposure in an incident case-control study of adult asthma. Eur Respir J (2006) 1.04
Placental transport and metabolism in fetal overgrowth -- a workshop report. Placenta (2006) 1.03
Degree and clinical relevance of sensitization to common allergens among adults: a population study in Helsinki, Finland. Clin Exp Allergy (2006) 1.03
Src family kinase-inhibitor PP2 reduces focal ischemic brain injury. Acta Neurol Scand (2004) 1.02
Asthma during the primary school ages--prevalence, remission and the impact of allergic sensitization. Allergy (2006) 1.02
Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis. J Antimicrob Chemother (1983) 1.01
Quantitative estimation of abnormal microheterogeneity of serum transferrin in alcoholics. Pharmacol Biochem Behav (1980) 1.01
Allergic rhinoconjunctivitis doubles the risk for incident asthma--results from a population study in Helsinki, Finland. Respir Med (2011) 1.01
Incidence of asthma in adults--report from the Obstructive Lung Disease in Northern Sweden Study. Allergy (1997) 1.00
Time trends in asthma and wheeze in Swedish children 1996-2006: prevalence and risk factors by sex. Allergy (2009) 1.00
Smoking, respiratory symptoms, and diseases : a comparative study between northern Sweden and northern Finland: report from the FinEsS study. Chest (2001) 0.99
MR imaging of cerebrospinal fluid dynamics in health and disease. On the vascular pathogenesis of communicating hydrocephalus and benign intracranial hypertension. Acta Radiol (1994) 0.99
Estimated prevalences of respiratory symptoms, asthma and chronic obstructive pulmonary disease related to detection rate in primary health care. Scand J Prim Health Care (2001) 0.98
The Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortality. Clin Respir J (2008) 0.97
Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetes. Curr Med Res Opin (2010) 0.96
Remission of asthma in the middle aged and elderly: report from the Obstructive Lung Disease in Northern Sweden study. Thorax (1999) 0.96
Characterization of a paramyxovirus isolated from the brain of a piglet in Mexico. Arch Virol (1986) 0.96
Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly. Eur Respir J Suppl (2003) 0.96
Neuropeptide tyrosine in the rat adrenal gland--immunohistochemical and in situ hybridization studies. Neuroscience (1988) 0.96
Socio-economic status is related to incidence of asthma and respiratory symptoms in adults. Eur Respir J (2006) 0.96
A Lotus japonicus cDNA encoding an alpha subunit of a heterotrimeric G-protein. Plant Physiol (1994) 0.95
Incidence rates and risk factors for asthma among school children: a 2-year follow-up report from the obstructive lung disease in Northern Sweden (OLIN) studies. Respir Med (2002) 0.95
Drug and treatment costs in Parkinson's disease patients in Sweden. Acta Neurol Scand (2011) 0.95
Incidence of physician-diagnosed asthma in adults--a real incidence or a result of increased awareness? Report from The Obstructive Lung Disease in Northern Sweden Studies. Respir Med (2001) 0.95
Prevalence and risk factors for asthma and chronic bronchitis in the capitals Helsinki, Stockholm, and Tallinn. Respir Med (2002) 0.94
Abstinence fear in methadone maintenance withdrawal: a possible obstacle for getting off methadone. Subst Use Misuse (1997) 0.94
Survival of mammalian cells exposed to ultrahigh dose rates from a laser-produced plasma x-ray source. Radiology (1999) 0.93
Magnetic resonance imaging in primary amyloidosis. Acta Radiol (1987) 0.93
Incidence and remission of asthma in schoolchildren: report from the obstructive lung disease in northern Sweden studies. Pediatrics (2001) 0.92
Gestational and hormonal regulation of human placental lipoprotein lipase. J Lipid Res (2006) 0.91
Consumer contributions in developing clinical practice guidelines. J Nurs Care Qual (2000) 0.91
Cigarette smoking is associated with high prevalence of chronic rhinitis and low prevalence of allergic rhinitis in men. Allergy (2013) 0.91
Central norepinephrine metabolism during alcohol intoxication in addicts and healthy volunteers. Science (1981) 0.90
An attempt to characterize malignant lymphoma in spleen, liver and lymph nodes with magnetic resonance imaging. Acta Radiol (1988) 0.90
Improved formulae for signal amplitudes in repeated NMR sequences: applications in NMR imaging. Magn Reson Med (1986) 0.90
Clinical conditions in alcoholics during long-term abstinence: a descriptive, longitudinal treatment study. Alcohol (1985) 0.89
5-Hydroxyindoleacetic acid in cerebrospinal fluid in alcoholic patients under different clinical conditions. Alcohol (1985) 0.89
Increase of asthma in adults in northern Finland?--a report from the FinEsS study. Allergy (2001) 0.89
Endorphin levels in human cerebrospinal fluid during alcohol intoxication and withdrawal. Psychopharmacology (Berl) (1982) 0.89